Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy. (2021)

First Author: Lilien C
Attributed to:  Oxford P2D: From Technologies to Therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/acn3.51417

PubMed Identifier: 34453498

Publication URI: http://europepmc.org/abstract/MED/34453498

Type: Journal Article/Review

Volume: 8

Parent Publication: Annals of clinical and translational neurology

Issue: 10

ISSN: 2328-9503